Spyre Therapeutics, Inc. (SYRE)
74.05
-0.27
(-0.36%)
USD |
NASDAQ |
May 22, 16:00
73.15
-0.90
(-1.22%)
After-Hours: 20:00
Spyre Therapeutics Market Cap : 6.431B for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tyra Biosciences, Inc. | 1.931B |
| Cogent Biosciences, Inc. | 5.582B |
| Revolution Medicines, Inc. | 32.22B |
| Apellis Pharmaceuticals, Inc. | 5.253B |
| Replimune Group, Inc. | 405.43M |
Market Cap Related Metrics
| Price to Book Value | 12.49 |
| Price | 74.05 |
| Earnings Yield | -3.18% |